The landscape of dementia diagnosis has advanced substantially with the appearance of sophisticated biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent checks that can detect Alzheimer's pathology many years just before signs or symptoms arise. Though these technological advances signify exceptional progress in knowledge